USTR requests comments on extending product exclusions, China Section 301 investigation (COVID-19)
Interim, 75-day extension of the COVID-19-related product exclusions to allow for consideration of public comments
China Section 301 investigation (COVID-19)
The Office of the United States Trade Representative (USTR) posted on its website a notice and request for comments concerning the Section 301 investigation of China’s acts, policies, and practices related to technology transfer, intellectual property, and innovation.
According to a related release, the USTR is seeking public comments on whether to further extend COVID-19-related product exclusions in the Section 301 investigation. The exclusions, covering 81 medical-care products, were initially granted in December 2020 and are scheduled to expire on February 28, 2023. Read TradeNewsFlash
The notice and request for comments [PDF 153 KB] also announces an interim, 75-day extension of the 81 COVID-19-related product exclusions to allow for consideration of public comments.
For more information, contact a professional with KPMG’s Trade & Customs services:
Doug Zuvich |
John L. McLoughlin |
Andy Siciliano |
Steve Brotherton |
Luis (Lou) Abad |
Irina Vaysfeld |
Amie Ahanchian |
Christopher Young |
Gisele Belotto |
George Zaharatos |
Andy Doornaert |
Jessica Libby Principal E: jlibby@kpmg.com |
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 3712, 1801 K Street NW, Washington, DC 20006.